Case Report

Published on 13 Nov 2024

Renal microangiopathy induced by lenvatinib in hepatocellular carcinoma: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Cheng Xue
Linlin Cui
Jiaxin Chen
Yang Liu
Yufei Deng
Wenyi Xu
Zhiguo Mao
Jun Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420377

133 views

Review

Accepted on 12 Nov 2024

Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application

in Pharmacology of Anti-Cancer Drugs

Murshid Imam
Jiale Ji
Zhijie Zhang
Shunchao Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1493188

Original Research

Published on 12 Nov 2024

Calycosin alleviates ferroptosis and attenuates doxorubicin-induced myocardial injury via the Nrf2/SLC7A11/GPX4 signaling pathway

in Pharmacology of Anti-Cancer Drugs

Quancheng Han
Jingle Shi
Yiding Yu
Huajing Yuan
Yonghong Guo
Xiujuan Liu
Yitao Xue
Yan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497733

134 views

Original Research

Accepted on 11 Nov 2024

Bufonis venenum extract loaded novel cholesterol-free liposome for the treatment of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Siqi Yang
Zhe Li
Jinshuai Lan
Ming Li
Ya Wu
Liyan Sun
Yue Ding
Tong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486742

Review

Published on 11 Nov 2024

EAF2: a tumor suppressor gene with multi-aspect functions

in Pharmacology of Anti-Cancer Drugs

Wen-Tong Ji
Chun-Guo Cui
Yao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440511

151 views

Original Research

Published on 11 Nov 2024

Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles

in Pharmacology of Anti-Cancer Drugs

Yuxuan Liu
Fuxu Yang
Zhimin Li
Ting Wang
Yeteng Mu
Yuxin Fan
Han Xue
Xiuli Hu
Xingang Guan
Hongxia Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1487940

165 views

Original Research

Accepted on 08 Nov 2024

Anti-Tumor and Anti-Metastatic Effects of RRx-001 on Hepatocellular Carcinoma: Mechanisms of Action and Therapeutic Potential

in Pharmacology of Anti-Cancer Drugs

Guohong Yan
Shuqi Zhao
Meifeng Chen
Shutian Mo
Hailian Huang
Yuan Liao
Ziyan Lu
Jiaming Liang
Shuxin Wei
Chuangye Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1469825

Review

Published on 08 Nov 2024

Exploring exosomes: novel diagnostic and therapeutic frontiers in thyroid cancer

in Pharmacology of Anti-Cancer Drugs

Sicheng Zhang
Yan Yang
Dianri Wang
Xueting Yang
Yongcong Cai
Chunyan Shui
Ruoyi Yang
Wen Tian
Chao Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1431581

169 views

Original Research

Published on 08 Nov 2024

Prognostic characteristics and drug sensitivity analysis of hepatocellular carcinoma based on histone modification-related genes: a multi-omics integrated study revealing potential therapeutic targets and individualized treatment strategies

in Pharmacology of Anti-Cancer Drugs

Ping Sun
Zheng Ding
Juan Chen
Kezhen Ou
Dianjie Zhou
Rui Li
Tianxiang Gu
He Sun
Ying Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1489469

173 views

Original Research

Published on 07 Nov 2024

A real-world study of adverse drug reactions of two isocitrate dehydrogenase inhibitor based on the US FDA adverse event reporting system and VigiAccess databases

in Pharmacology of Anti-Cancer Drugs

Mengmeng Peng
Qian Guo
Zihan Dang
Baiquan Zhang
Manjuan Li
Zixuan Wang
Xuemian Lu
Jie Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1489045

249 views

Review

Published on 07 Nov 2024

Inspired by an ancient Chinese Medicine prescription: the modern significance and potential of Yiyi Fuzi Baijiang San in treating diseases

in Pharmacology of Anti-Cancer Drugs

Yuli Zhang
Lu Zhang
Ni Chai
ZhiQiang Wan
Hua Sui

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1465387

201 views

Original Research

Published on 06 Nov 2024

Tinosporae Radix attenuates acute pharyngitis by regulating glycerophospholipid metabolism and inflammatory responses through PI3K-Akt signaling pathway

in Pharmacology of Anti-Cancer Drugs

Lijie Lu
Chengfeng Huang
Yongfeng Zhou
Huajuan Jiang
Cuiping Chen
Jinyu Du
Tao Zhou
Feiyan Wen
Jin Pei
Qinghua Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491321

469 views

Review

Published on 05 Nov 2024

PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond

in Pharmacology of Anti-Cancer Drugs

Sameh Saber
Rasha Abdelhady
Mai A. Elhemely
Elsayed A. Elmorsy
Rabab S. Hamad
Mustafa Ahmed Abdel-Reheim
Attalla F. El-kott
Mohammed A. AlShehri
Kareem Morsy
Ali S. AlSheri

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1475998

520 views

Systematic Review

Published on 05 Nov 2024

Systematic review of Buzhong Yiqi method in alleviating cancer-related fatigue: a meta-analysis and exploratory network pharmacology approach

in Pharmacology of Anti-Cancer Drugs

Ji Zeng
Qi Wu
Xu-Dong Meng
Jian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1451773

347 views

Review

Published on 05 Nov 2024

Emerging strategies to overcome ovarian cancer: advances in immunotherapy

in Pharmacology of Anti-Cancer Drugs

Tatiana Massariol Pimenta
Josiany Carlos de Souza
Bárbara da Silva Martins
Solenny Maria Silva Butzene
José Matheus Simões Padilha
Milleny Ganho Marçal
Guilherme dos Santos Elias
Leticia Batista Azevedo Rangel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1490896

450 views

Correction

Published on 04 Nov 2024

Corrigendum: Network-based prediction of anti-cancer drug combinations

in Pharmacology of Anti-Cancer Drugs

Jue Jiang
Xuxu Wei
YuKang Lu
Simin Li
Xue Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1495634

180 views

Navigation group

Articles

Renal microangiopathy induced by lenvatinib in hepatocellular carcinoma: a case report and literature review

Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application

Calycosin alleviates ferroptosis and attenuates doxorubicin-induced myocardial injury via the Nrf2/SLC7A11/GPX4 signaling pathway

Bufonis venenum extract loaded novel cholesterol-free liposome for the treatment of hepatocellular carcinoma

EAF2: a tumor suppressor gene with multi-aspect functions

Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles

Anti-Tumor and Anti-Metastatic Effects of RRx-001 on Hepatocellular Carcinoma: Mechanisms of Action and Therapeutic Potential

Exploring exosomes: novel diagnostic and therapeutic frontiers in thyroid cancer

Prognostic characteristics and drug sensitivity analysis of hepatocellular carcinoma based on histone modification-related genes: a multi-omics integrated study revealing potential therapeutic targets and individualized treatment strategies

A real-world study of adverse drug reactions of two isocitrate dehydrogenase inhibitor based on the US FDA adverse event reporting system and VigiAccess databases

Inspired by an ancient Chinese Medicine prescription: the modern significance and potential of Yiyi Fuzi Baijiang San in treating diseases

Tinosporae Radix attenuates acute pharyngitis by regulating glycerophospholipid metabolism and inflammatory responses through PI3K-Akt signaling pathway

PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond

Systematic review of Buzhong Yiqi method in alleviating cancer-related fatigue: a meta-analysis and exploratory network pharmacology approach

Emerging strategies to overcome ovarian cancer: advances in immunotherapy

Corrigendum: Network-based prediction of anti-cancer drug combinations